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Background: The frequent treatment failures with empirical therapy observed in some hospitalized 
typhoid fever patients in the last decade is of great concerned to both public and private physicians 
owing to the wide spread and circulation of antibiotic resistant strains of S. typhi 
Methods: This study assessed the trends in antibiotic resistance in 235 Salmonella typhi stains 
isolated by standard procedures from blood and/stool samples of hospitalized patients from 1997 to 
2003. All the isolates were subjected to antimicrobial susceptibility testing using the following 
antibiotics: chloramphenicol, Ampicillin, cotrimoxazole, tetracycline, nalidixic acid, ciprofloxacin 
and ofloxacin. Susceptibility and resistance were determined by standard methods.  
Results:  From 1997 through 2003, 188 (80%) of 235 isolates were multiple drug resistant (MDR), 
chloramphenicol being the most resisted antibiotic (83.0%) followed by Ampicillin (81.7%). Only one 
strain was resistant to both ciprofloxacin and ofloxacin. Also the prevalence of chloramphenicol 
resistant isolates increased gradually from 72.4% in 1997 to 89.2% in 2003. Similar trends were 
recorded for other four antibiotics tested, even for single drug resistance S. typhi isolates. Our study 
confirmed increased in circulation of MDR-S. typhi isolates over relatively short period.  
Conclusion: We hereby suggest for a while the immediate stoppage of prescription of 
chloramphenicol and other first line antibiotics used in the treatment of typhoid fever in Nigeria. 
The use of more effective drugs such as ofloxacin and ciprofloxacin would go a long way in stemming 
the prevalence of persons with chronic infections as well as reducing the widespread of MDR-S. typhi 
strains in our environment, but our fear is that resistance is likely to develop unless these valuable 




Typhoid fever remains an important public 
health problem particularly in developing 
countries with approximately 10 millions cases 
which result in 700,000 deaths annually1,2 . The 
situation is different in developed countries such 
as the USA and the UK where the incidence is 
low and most cases are found in international 
travelers3. The antibiotics that form the mainstay 
therapy for typhoid fever patients in developing 
countries are chloramphenicol, Ampicillin and 
cotrimoxazole. Resistance strains of Salmonella 
typhi to these antibiotics have emerged and  
continued to be of clinical significance. In 
Nigeria, typhoid fever is among the major 
widespread diseases affecting both young 
children and young adults in their productive 
years  as a result of many interrelated factors 
such as increase urbanization, inadequate 
supplies of potable water, regional movement of 
large numbers of immigrant workers, inadequate 
facilities for processing human wastes, over-
burdened health care delivery systems and 
indiscriminate use of antibiotics that contributed 
to the development of antibiotic resistant S. 
typhi4, 5.Chloramphenicol has been employed 
successfully in the management of typhoid fever 
in Nigeria because S. typhi strains recovered 
from patients were routinely susceptible4,6 . The 
efficacy of this antibiotic and other first line 
antibiotics such as Ampicillin, cotrimoxazole 
and tetracycline became doubtful following 
unprecedented upsurge in enteric fever in early 
1990s7,8,9. From 1997 through 1998, study on the 
prevalent of multiple drug resistance (MDR) in 
S. typhi was conducted in Lagos, and most S. 
typhi strains isolated were resistant to these 
antibiotics10. However, once drug resistant S. 
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significant public health problem, a pattern that 
has been repeated in many parts of the world 
where S. typhi is prevalent2,11,12,13,14. Previous 
reports elsewhere have indicated either clonal 
spread and/or extra chromosomal genes to be the 
potential mechanisms for high level of reduced 
susceptibility15. In Nigeria, evidence of plasmid-
mediated MDR S. typhi associated with typhoid 
fever complications has been documented 
recently5. Recently, increasing cases of typhoid 
fever complications among hospitalized patients 
has been speculated among public and private 
clinicians and health workers to be associated 
with the late reporting of patients to the hospitals 
at the on set of illness owning to the attitude of 
self medications among other factors. This 
situation is worrisome and has led to prolong 
stay of patients in hospitals because of frequent 
cases of treatment failures with the empirical 
therapy. It is on this premise that the current 
study was initiated with a view to assessing the 
trends in antibiotic resistance in S. typhi 
recovered from hospitalised typhoid fever 
patients from 1997 to 2003 and to provide 
information on the possible alternative 
antibiotics that could be used for the treatment 
of typhoid fever and its complications.. 
Methods 
Patient population and study Centre: - A 
retrospective study of 235 S. typhi isolates 
recovered from patients whose blood and/or 
stool samples were brought to the Central Public 
Health Laboratory Services (CPHLS), Yaba was 
conducted in other to assess antimicrobial 
resistance patterns of the isolates. CHPLS is a 
referral laboratory that serves an estimated 
population of 12 million people of Lagos State 
and had been established for the evaluation and 
processing of laboratory samples from patients 
admitted to hospitals and/or undergoing 
treatment of infectious diseases in children and 
adults. The subjects in this study were patients 
who presented with two or more of the 
following symptoms, diarrhoea, vomiting, 
headache, loss of appetite, malaise and 
abdominal pain and had been diagnosed for 
typhoid fever based on Widal agglutination test 
(from the diagnostic centres) and had been on at  
least one of the first line antibiotics but did not 
response to treatment before reported and/or 
admitted to the hospital. 
 
Bacteriology – 
Fresh aliquot of each of the patients blood 
collected aseptically was directly inoculated into 
brain heart infusion (BHI) broth (Oxoid U.K) in 
1:9 blood broth ratio while stool specimens 
collected in Selenite F broth (Oxoid, U.K) 
incubated at 37oC aerobically for 18-24hrs. 
Subcultures were made from the broths into 
Salmonella- Shigella agar and Desoxycholate 
citrate agar (Oxoid, U.K.) and plates further 
incubated at 37oC for 18-24 hrs. In negative 
cases, subcultures were repeated from the 
infusion broth daily for 7 consecutive days 
before discarded. Bacterial colonies were 
identified using standard procedures16. 
 
Antimicrobial susceptibility testing  
Susceptibility to Ampicillin (25ug) 
chloramphenicol (30ug), co-trimoxazole (25ug), 
tetracycline (50ug) and nalidixic acid (30ug), 
ciprofloxacin (20ug) and Ofloxacin (20ug) was 
determined for all isolates by the disk diffusion 
Kirby Bauer method30. After, 1999, 
susceptibility testing was performed using the 
reference broth micro dilution methods 
recommended by National Committee for 
Clinical Laboratory Standard (NCCLS)31. 
Susceptibility was determined using the 
established NCCLS break points. For Ampicillin 
and chloramphenicol, break points 8.0 and 
16.0ug/ml were used for intermediate and 
resistant respectively. Tetracycline and 
cotrimoxazole > 4.0ug/ml for intermediate and > 
8.0ug/ml for resistant, while nalidixic acid > 
4.0ug;ml for resistant was used. The minimum 
inhibitory concentration (MIC) of < 0.03ug/ml 
was taken to be fully sensitive for ciprofloxacin 
and ofloxacin. For analysis in this study, both 
intermediate and resistant categories were 
considered to be resistant. Escherichia coli 
ATCC 25922, E. coli ATCC 35218 and 
Pseudomonas aeruginosa ATCC 27853 were 
used as controls in susceptibility testing. MDR 
S.- typhi infection in this study was defined as an 
infection due to S. typhi isolate that was resistant 
to three or more antibiotics. 
Results 
From 1997 through 2003, a total of 235 S. typhi 
isolates were identified in blood and/stool 





East and Central African Journal of Surgery Volume 12 Number 1     -   April 2007 
 
85 
three antibiotics given a prevalence of 80% 
MDR- S. typhi in this study. The highest number 
of S. typhi (16.1%) was recorded in 2000. Our 
study showed that for S. typhi isolates in 
aggregate, the highest percentage of resistance 
was recorded in chloramphenicol (83.0% of 
isolates) followed closely by Ampicillin (81.7% 
of isolates) and cotrimoxazole (80.4% of 
isolates) (Table 1). However, resistant to 
individuals antibiotics varied slightly during the 
periods under study. For instance, the prevalence 
of chloramphenicol resistant isolates which was 
72.4% in 1997 increased gradually to 89.2% by 
year 2003. Similar trend was also observed for 
Ampicillin, cotrimoxazole and tetracycline. 
Only one strain of S. typhi was found to be 
resistant to ciprofloxacin and ofloxacin 
throughout the periods. Also, the prevalence of 
MDR-S. typhi isolates was similar to that of S. 
typhi isolates with single drug résistance 
(including nalidixic acid) with gradual increase 
from 70.0% in 1997 to 88.6% in 2002 but later 
decreased in 2003.  
 
Table 1. Antibiotic Resistant Salmonella Typhi Isolated From Hospitalized Patients From 1997-2004 In                  




Number of`Isolates resistant to each antimicrobials (%) Number 
of MDR 
  Amp Chl Tet Cot Nal Cip Ofl  










0 (0.0) 0 (0.0) 20 (70.0) 










0 (0.0) 0 (0.0) 28 (75.7) 










0 (0.0) 0 (0.0) 20 (76.9) 










0 (0.0) 0 (0.0) 30 (79.0) 










0 (0.0) 0 (0.0) 28 (84.8) 










0 (0.0) 0 (0.0) 31 (88.6) 










0 (0.0) 0 (0.0) 31 (83.8) 










1 (2.5) 1 (2.5) 33 (84.6) 










1 (0.4) 1 (0.4) 221 (80.7) 
 
Amp = ampicillin, Chl = chloramphenicol, Tet = tetracycline, Cot = cotrimoxazole, Nal = nalidixic acid,  
Cip = ciprofloxacin, Ofl  = ofloxacin 
 
Discussion 
The frequent treatment failures with empirical 
therapy observed in some hospitalized typhoid 
fever patients in the last decade is of great 
concerned to both public and private physicians 
owing to the wide spread and circulation of 
antibiotic resistant strains of S. typhi. Our study 
showed that 70%, 72.4%, 70% and 72.4% of S. 
typhi isolates examined in 1997 were resistant to 
Ampicillin, chloramphenicol, tetracycline and 
cotrimoxazole respectively. There was increased 
in the resistant recorded to all the 
aforementioned antibiotics in the subsequent 
years. For example 79.0%, 81.6%, 76.3% and 
81.6% as well as 86.5%, 89.2%, 83.8% and 
81.1% of the isolates were resistant to 
Ampicillin, chloramphenicol, tetracycline and 
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(Table 1). The prevalence of MDR- S. typhi 
increased from 70.0% in 1997 to 83.3% in 2003. 
The increasing trends of MDR- S. typhi recorded 
might have arisen from drug abused. This is 
because therapeutic intervention in suspected 
cases of typhoid fever due to attitude of self 
medications usually prevents early reporting of 
patients to the hospitals at the on set of the 
disease symptoms except where complications 
had occurred. This is because our present study 
was hospital-based and close observations 
revealed that most of the patients had been on 
antibiotic self medications (at least one of the 
first line antibiotics) and only untreated cases of 
typhoid fever by self medications were brought 
to the hospitals. Severe, refractory or 
complicated infections have been attributed to 
increase chloramphenicol resistance in strains of 
S. typhi in some parts of the world17, a situation 
that seems to have come to stay in our 
environment in recent time. However,  this study 
is in contrast to some reports from African 
countries such as Senegal and Egypt, where 
significant shift in the antibiotics susceptibility 
to the first line antibiotics have been recorded. 
For instance in Egypt > 60% prevalence of 
MDR- S. typhi was recorded in 1987 but 
gradually decreased to only 5% in 200018. Also 
in Senegal, there was a shift in resistant patterns 
of S. typhi isolates to the first line antibiotics 
from over 50% recorded in 1997 to about 3% 
resistant recorded in 200219 (Similar 
observations of increased in susceptibility of S. 
typhi to the first line antibiotics particularly 
chloramphenicol had since been made in India 
and Bangladesh20,21 and were attributed to the 
restricted use of chloramphenicol for few years. 
The implication of high prevalence of MDR-S. 
typhi recorded  in our study is that efficacy of 
the relatively cheap empirical therapy for 
typhoid fever patients in  Nigeria is now 
doubtful and thus call for urgent attention. More 
importantly, the increasing trends of MDR -S. 
typhi may spread to neighbouring countries of 
Africa that recorded low prevalence of MDR-
S.typhi recently and as well to other parts of the 
world particularly among the travellers returning 
from this region if the unprecedented upsurge 
remains unchecked.  
 
In this study we observed an increased in the 
emergence of nalidixic acid resistant S. typhi 
from 42.0% in 1997 to 57.1% in 2002 and 
decreased slightly to 56.8% in 2003. This result 
is surprising as nalidixic acid is not frequently 
prescribed by physicians in most clinics and 
hospitals in Nigeria. However, the increasing 
emergence of nalidixic resistant S. typhi may 
probably be attributed to the use of quinolone 
antibiotics in animal feeds in the country. 
Several workers have reported from elsewhere 
that the use of quinolones in food animals have 
led to the rapid emergence of resistant 
Salmonella infections to humans22,23,24,25,26,27 
Studies have also revealed that antimicrobial 
agents used in agriculture and closely related 
agents used in human medicine have been 
exerting selective pressure on their target 
bacteria particularly Salmonella, Campylobacter 
and Escherichia coli2428,29, a situation that might 
have arisen in Nigeria. 
 
It is interesting to note that MDR- S. typhi 
strains recovered from patients from 1997 to 
date were all sensitive to ciprofloxacin and 
ofloxacin except one (1/26) MDR- S. typhi 
isolated in 1999 which was resistant to both 
ciprofloxacin and ofloxacin. Clinical history of 
the patient revealed an earlier diagnosis of 
human immunodeficiency virus – associated 
acquired immune deficiency syndrome. This 
unusual isolation of fluoroquinolone resistant S. 
typhi was first of its kind and thus calls for  
urgent attention.  In spite of this unusual 
observation, these two antibiotics seem to offer 
new hope for the treatment of typhoid fever and 
its complications. To date fluroquinolone 
antibiotics are still under strict prescription of 
clinicians and are less abused due to high cost of 
their procurement in Nigeria. Although, in other 
parts of the world such as South-east Asia and 
the United Kingdom3,15 there have been rapid 
emergency of fluroquinolones resistance in S. 
typhi isolates but no such  previous observation 




This study recorded high prevalence as well as 
increased in the trend of MDR-S. typhi  
throughout the 7 year-period. Chloramphenicol, 
ampicillin cotrimoxazole and tetracycline are no 
longer effective for treatment of typhoid fever 
and its complications. The use of more effective 
antibiotics such as ofloxacin and ciprofloxacin 
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prevalence of persons with chronic infections as 
well as decreasing the circulation and 
widespread of MDR- S. typhi strains,thus 
prevent the spread to other African countries. 
But our fear is that resistance is likely to develop 
unless these valuable drugs are used prudently. 
It is on this note that we suggest the followings: 
1. Comprehensive enlightenment 
campaigns on early reporting of patients 
to the hospital once the symptoms of 
typhoid fever are noticed, and the 
implication of engaging in antibiotics 
self medication.  
2. Enhancement and prudent use of 
laboratory services in order to back up 
clinical diagnosis is essential.  
3. Restriction and/or immediate stoppage 
for a while, the use of chloramphenicol, 
ampicillin cotrimoxazole and 
tetracycline for the treatment of typhoid 
fever and its complications in Lagos , 
Nigeria..  
4. Enforcement of existing laws relating to 
drug sales that will only permit qualified 
medical and other authorized personnel 
to handle antimicrobial  drugs  in 
developing countries and  
5. Constant collection and monitoring of 
data that document antibiotic resistance 
patterns is equally advocated.          
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